Company News
Jenburkt Pharmaceuticals Board Meeting for Q1 FY27 Results
Jenburkt Pharmaceuticals schedules its board meeting for 6th August 2026 to review Q1 FY27 standalone unaudited financial results.
The intimation is a regulatory filing submitted to BSE Ltd. under SEB
